First Eagle Investment Management’s Quest Diagnostics DGX Stock Holding History

First Eagle Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Buy	7,606 +4,606	+154%	+$904K	﹤0.01%	343
2026 Q1	$588K	Sell	3,000 -935	-24%	-$182K	﹤0.01%	368
2025 Q4	$683K	Buy	3,935 +100	+3%	+$18.2K	﹤0.01%	356
2025 Q3	$731K	Sell	3,835 -1,862	-33%	-$330K	﹤0.01%	349
2025 Q2	$1.02M	Buy	5,697 +148	+3%	+$25.7K	﹤0.01%	342
2025 Q1	$939K	Buy	5,549 +600	+12%	+$98.6K	﹤0.01%	349
2024 Q4	$747K	Hold	4,949	–	–	﹤0.01%	367
2024 Q3	$768K	Buy	4,949 +500	+11%	+$74.7K	﹤0.01%	343
2024 Q2	$609K	Buy	4,449 +600	+16%	+$82.2K	﹤0.01%	359
2024 Q1	$512K	Hold	3,849	–	–	﹤0.01%	370
2023 Q4	$531K	Hold	3,849	–	–	﹤0.01%	366
2023 Q3	$469K	Buy	3,849 +178	+5%	+$23.7K	﹤0.01%	363
2023 Q2	$516K	Hold	3,671	–	–	﹤0.01%	346
2023 Q1	$519K	Buy	3,671 +3,397	+1,240%	+$486K	﹤0.01%	349
2022 Q4	$42.9K	Sell	274 -25	-8%	-$3.59K	﹤0.01%	368
2022 Q3	$37K	Buy	299 +168	+128%	+$22.1K	﹤0.01%	368
2022 Q2	$17K	Hold	131	–	–	﹤0.01%	362
2022 Q1	$18K	Buy	+131	New	+$18.3K	﹤0.01%	367

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

First Eagle Investment Management's DGX Position: Q2 2026 in Review

First Eagle Investment Management increased its Quest Diagnostics (DGX) stake by 154% in Q2 2026, buying an estimated $904K and bringing the position to 7,606 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #343.

First Eagle Investment Management first reported a position in DGX in Q1 2022 and has held it in 18 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

First Eagle Investment Management held 7,606 shares of Quest Diagnostics worth $1.61M as of Q2 2026.
First Eagle Investment Management bought 4,606 Quest Diagnostics shares in Q2 2026, an estimated $904K.
Quest Diagnostics made up ﹤0.01% of First Eagle Investment Management's portfolio in Q2 2026, its #343 holding.
First Eagle Investment Management first reported a position in Quest Diagnostics in Q1 2022 and has held it in 18 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.